NATHBIOGENOther Agricultural Products
Nath Bio Genes India Limited — Profit & Loss Statement
₹129.02
-6.22%
Nath Bio Genes India Limited Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -17151.30 | -26.59 Cr | — |
| Tax Rate For Calcs | 0.05 | 0.05 | 0.03 | 0.30 | — |
| Normalized EBITDA | 54.34 Cr | 50.49 Cr | 48.80 Cr | 38.42 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | -0.05 Cr | -88.65 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | -0.05 Cr | -88.65 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 38.06 Cr | 36.17 Cr | 35.01 Cr | -67.39 Cr | — |
| Reconciled Depreciation | 3.82 Cr | 3.26 Cr | 3.01 Cr | 3.08 Cr | — |
| Reconciled Cost Of Revenue | 135.55 Cr | 133.57 Cr | 114.61 Cr | 123.97 Cr | — |
| EBITDA | 54.34 Cr | 50.49 Cr | 48.75 Cr | -50.22 Cr | — |
| EBIT | 50.53 Cr | 47.23 Cr | 45.74 Cr | -53.31 Cr | — |
| Net Interest Income | -10.48 Cr | -9.11 Cr | -10.34 Cr | -9.55 Cr | — |
| Interest Expense | 10.48 Cr | 9.11 Cr | 9.57 Cr | 10.13 Cr | — |
| Normalized Income | 38.06 Cr | 36.17 Cr | 35.06 Cr | -5.33 Cr | — |
| Net Income From Continuing And Discontinued Operation | 38.06 Cr | 36.17 Cr | 35.01 Cr | -67.39 Cr | — |
| Total Expenses | 318.93 Cr | 286.02 Cr | 255.33 Cr | 243.75 Cr | — |
| Diluted Average Shares | 1.92 Cr | 1.86 Cr | 1.90 Cr | 1.90 Cr | — |
| Basic Average Shares | 1.92 Cr | 1.86 Cr | 1.90 Cr | 1.90 Cr | — |
| Diluted EPS | 20.14 | 21.34 | 18.43 | -35.55 | — |
| Basic EPS | 20.14 | 21.34 | 18.43 | -35.55 | — |
| Diluted NI Availto Com Stockholders | 38.60 Cr | 39.62 Cr | 35.01 Cr | -67.39 Cr | — |
| Net Income Common Stockholders | 38.60 Cr | 39.62 Cr | 35.01 Cr | -67.39 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 38.60 Cr | 39.62 Cr | 35.01 Cr | -67.39 Cr | — |
| Net Income Including Noncontrolling Interests | 38.60 Cr | 39.62 Cr | 35.01 Cr | -67.39 Cr | — |
| Net Income Extraordinary | 0.54 Cr | 3.45 Cr | 0.00 | 0.00 | — |
| Net Income Continuous Operations | 38.06 Cr | 36.17 Cr | 35.01 Cr | -67.39 Cr | — |
| Tax Provision | 1.98 Cr | 1.95 Cr | 1.15 Cr | 3.95 Cr | — |
| Pretax Income | 40.04 Cr | 38.12 Cr | 36.16 Cr | -63.43 Cr | — |
| Other Non Operating Income Expenses | 4.55 Cr | 0.63 Cr | 0.10 Cr | 0.10 Cr | — |
| Special Income Charges | 0.00 | 0.00 | -0.05 Cr | -88.65 Cr | — |
| Net Non Operating Interest Income Expense | -10.48 Cr | -9.11 Cr | -10.34 Cr | -9.55 Cr | — |
| Interest Expense Non Operating | 10.48 Cr | 9.11 Cr | 9.57 Cr | 10.13 Cr | — |
| Operating Income | 45.98 Cr | 46.60 Cr | 46.04 Cr | 34.61 Cr | — |
| Operating Expense | 183.38 Cr | 152.45 Cr | 140.72 Cr | 119.78 Cr | — |
| Other Operating Expenses | 30.09 Cr | 27.94 Cr | 72.34 Cr | 53.04 Cr | — |
| Depreciation And Amortization In Income Statement | 3.82 Cr | 3.26 Cr | 3.01 Cr | 3.08 Cr | — |
| Depreciation Income Statement | 3.82 Cr | 3.26 Cr | 1.37 Cr | 1.48 Cr | — |
| Selling General And Administration | 116.97 Cr | 93.00 Cr | 29.09 Cr | 26.46 Cr | — |
| Selling And Marketing Expense | 116.97 Cr | 93.00 Cr | 23.41 Cr | 19.81 Cr | — |
| Gross Profit | 229.36 Cr | 199.05 Cr | 186.75 Cr | 154.39 Cr | — |
| Cost Of Revenue | 135.55 Cr | 133.57 Cr | 114.61 Cr | 123.97 Cr | — |
| Total Revenue | 364.91 Cr | 332.62 Cr | 301.36 Cr | 278.36 Cr | — |
| Operating Revenue | 364.91 Cr | 332.62 Cr | 301.36 Cr | 278.36 Cr | — |
| Interest Income | — | 0.32 Cr | 0.02 Cr | 1.09 Cr | 1.21 Cr |
| Rent Expense Supplemental | — | 10.59 Cr | 9.47 Cr | 11.44 Cr | 15.12 Cr |
| Other Special Charges | — | -3.45 Cr | -49000.00 | 88.64 Cr | -0.07 Cr |
| Write Off | — | 0.02 Cr | 0.06 Cr | 75000.00 | 0.08 Cr |
| Total Other Finance Cost | — | 0.58 Cr | 0.79 Cr | 0.52 Cr | 0.96 Cr |
| Interest Income Non Operating | — | 0.32 Cr | 0.02 Cr | 1.09 Cr | 1.21 Cr |
| Amortization | — | 1.61 Cr | 1.64 Cr | 1.61 Cr | 1.60 Cr |
| Research And Development | — | 11.28 Cr | 9.37 Cr | 8.89 Cr | 9.15 Cr |
| General And Administrative Expense | — | 7.29 Cr | 5.68 Cr | 6.65 Cr | 5.09 Cr |
| Rent And Landing Fees | — | 3.46 Cr | 3.10 Cr | 3.03 Cr | 3.08 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Nath Bio Genes India Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.